Ulta Beauty rolls out Mediheal PDRN clinical K-beauty line to 1,400+ U.S. stores

Ulta expands K-beauty clinical offerings with Mediheal rollout

Nationwide launch brings vegan PDRN collection to more than 1,400 Ulta stores

Ulta Beauty is adding Mediheal’s PDRN Collection to its store shelves nationwide, introducing U.S. shoppers to the PDRN Lifting Pad, PDRN Lifting Serum and Rose PDRN Essential Sheet Mask. The products, which use a plant-derived PDRN sourced from rose, reach more than 1,400 Ulta locations on Feb. 11, 2026, giving the retailer a significant expansion in clinical-grade Korean skincare assortments.

Ulta positions the range to meet rising consumer demand for performance-driven formulas. Mediheal says the plant-based PDRN features a smaller molecular structure than traditional animal-derived alternatives, allowing deeper and faster skin absorption and delivering pore-tightening, lifting and skin-renewing effects. A company representative says U.S. shoppers are moving beyond brand recognition toward measurable outcomes, and Ulta expects the new range to drive in-store trials and broaden access to clinical K-beauty at multiple price points.

The rollout aligns with Ulta’s strategy to capture share in a sector that values dermatologically backed efficacy and ingredient transparency. By carrying a brand that boasts global sales milestones — including more than 32 million toner pads sold worldwide — Ulta enlarges its selection of treatment-oriented products and positions stores as destinations for science-focused skincare rather than purely cosmetic offerings.

Mediheal’s Korea success underpins U.S. expansion

Mediheal leverages its home-market leadership to support the Ulta push, having been the top-selling skincare brand at Olive Young for two consecutive years. The company frames the Ulta partnership as part of a broader plan to translate Korean market momentum into sustained growth in the United States through major retail partners and product innovation.

U.S. consumer trends favor clinical efficacy

Retailers such as Ulta are responding to a U.S. skincare market that increasingly prioritizes barrier-strengthening, prevention of aging signs, and transparent formulations. Industry observers say wider retail availability of clinically positioned K-beauty brands can accelerate consumer trials and shift mainstream demand toward measurable, dermatologist-developed products.